US Medicare Insulin Demo Could Expand To Other Drugs

 
• By Derrick Gingery

Eighty-eight insurers who offer Medicare Part D plans are interested in the demonstration project, which would limit insulin copays to $35.

Diabetes
Biosimilar insulin manufacturers are allowed to participate in the Part D demo, CMS Administrator Seema Verma said. • Source: Shutterstock

More from Medicare

More from Government Payers